ZA894392B - Pharmaceutical products - Google Patents

Pharmaceutical products

Info

Publication number
ZA894392B
ZA894392B ZA894392A ZA894392A ZA894392B ZA 894392 B ZA894392 B ZA 894392B ZA 894392 A ZA894392 A ZA 894392A ZA 894392 A ZA894392 A ZA 894392A ZA 894392 B ZA894392 B ZA 894392B
Authority
ZA
South Africa
Prior art keywords
hydrogen
nrr
azido
pharmaceutical products
synergistic
Prior art date
Application number
ZA894392A
Other languages
English (en)
Inventor
Robert Vince
Vince Robert
William M Shannon
M Shannon William
Original Assignee
Univ Minnesota
Southern Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Minnesota, Southern Res Inst filed Critical Univ Minnesota
Publication of ZA894392B publication Critical patent/ZA894392B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Formation And Processing Of Food Products (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA894392A 1988-06-10 1989-06-09 Pharmaceutical products ZA894392B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20516388A 1988-06-10 1988-06-10

Publications (1)

Publication Number Publication Date
ZA894392B true ZA894392B (en) 1990-08-29

Family

ID=22761073

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA894392A ZA894392B (en) 1988-06-10 1989-06-09 Pharmaceutical products

Country Status (9)

Country Link
EP (1) EP0346132B1 (cs)
JP (1) JPH0291022A (cs)
AT (1) ATE73335T1 (cs)
AU (1) AU627188B2 (cs)
DE (1) DE68900961D1 (cs)
DK (1) DK284189A (cs)
GR (1) GR3004628T3 (cs)
NZ (1) NZ229453A (cs)
ZA (1) ZA894392B (cs)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175292A (en) * 1988-01-20 1992-12-29 Regents Of The University Of Minnesota Intermediates for the preparation of dideoxycarbocyclic nucleosides
US5631370A (en) * 1988-01-20 1997-05-20 Regents Of The University Of Minnesota Optically-active isomers of dideoxycarbocyclic nucleosides
DE3901502C2 (de) * 1988-01-20 2002-06-13 Univ Minnesota Didesoxydehydrocarbocyclische Nucleoside, diese enthaltende pharmazeutische Formulierungen und Pyrimidinylamino-cyclopentenylcarbinol-Derivate
GB2243609B (en) * 1988-01-20 1992-03-11 Univ Minnesota Dideoxydidehydrocarbocyclic pyrimidines
GB8815265D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
US4939252A (en) * 1989-04-20 1990-07-03 Hoffmann-La Roche Inc. Novel intermediates for the preparation of Carbovir
DK0879056T3 (da) * 1996-01-23 2002-08-19 Icn Pharmaceuticals Modulation af Th1/Th2-cytokinekspression med ribavirin i aktiverede T-lymfocytter
BR9807473A (pt) * 1997-01-17 2000-03-21 Icn Pharmaceuticals Tratamentos de doença relacionados à citocina
GB9721780D0 (en) * 1997-10-14 1997-12-10 Glaxo Group Ltd Process for the synthesis of chloropurine intermediates
US5916594A (en) * 1997-12-22 1999-06-29 Schering Corporation Process of making solid ribavirin dosage forms
EP1321147A1 (en) * 1997-12-22 2003-06-25 Schering Corporation Orally administrable solid ribavirin dosage forms and process for making them
GB9903091D0 (en) * 1999-02-12 1999-03-31 Glaxo Group Ltd Therapeutic nucleoside compound
US7638496B2 (en) 2000-02-15 2009-12-29 Valeant Pharmaceuticals North America Nucleoside analogs with carboxamidine modified monocyclic base
MY164523A (en) 2000-05-23 2017-12-29 Univ Degli Studi Cagliari Methods and compositions for treating hepatitis c virus
EA007867B1 (ru) 2000-05-26 2007-02-27 Айденикс (Кайман) Лимитед Композиции для лечения флавивирусных и пестивирусных инфекций и способы их применения
HK1079981B (zh) * 2002-06-27 2007-10-12 Medivir Aktiebolag 含有阿巴卡韦和阿洛夫定的药物制剂及其用途
CN101172993A (zh) 2002-06-28 2008-05-07 埃迪尼克斯(开曼)有限公司 用于治疗黄病毒感染的2′-c-甲基-3′-o-l-缬氨酸酯核糖呋喃基胞苷
CA2506129C (en) 2002-11-15 2015-02-17 Idenix (Cayman) Limited 2'-branched nucleosides and flaviviridae mutation
WO2006122003A2 (en) * 2005-05-05 2006-11-16 Ardea Biosciences, Inc. Diaryl-purine, azapurines and -deazapurines as non-nucleoside reverse transcriptase inhibitors for treatment of hiv
JP5192807B2 (ja) * 2005-06-24 2013-05-08 ヤマサ醤油株式会社 シュードウリジン保護体の安定結晶

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4138562A (en) * 1977-02-09 1979-02-06 The Regents Of The University Of Minnesota Adenosine deaminase resistant antiviral purine nucleosides and method of preparation
US4362729A (en) * 1980-06-23 1982-12-07 The Regents Of The University Of Minnesota Alkoxyalkanoate esters of cyclaradine
US4636383A (en) * 1984-08-29 1987-01-13 Schering Corporation Interferon-cyclaradine combination
DE58902899D1 (de) * 1988-12-14 1993-01-14 Ciba Geigy Ag 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer.

Also Published As

Publication number Publication date
JPH0291022A (ja) 1990-03-30
NZ229453A (en) 1991-08-27
EP0346132A1 (en) 1989-12-13
DK284189A (da) 1989-12-11
GR3004628T3 (cs) 1993-04-28
EP0346132B1 (en) 1992-03-11
ATE73335T1 (de) 1992-03-15
AU627188B2 (en) 1992-08-20
DK284189D0 (da) 1989-06-09
AU3627289A (en) 1989-12-14
DE68900961D1 (de) 1992-04-16

Similar Documents

Publication Publication Date Title
ZA894392B (en) Pharmaceutical products
CA2100269A1 (en) Use of 1, 3-Oxathiolane Nucleoside Analogues in the Treatment of Hepatitis B
IL93050A0 (en) Pyrazolopyridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL101883A0 (en) Antiviral combinations and pharmaceutical compositions containing them
AU640137B2 (en) Novel arylpyridazines, their manufacture, use and medicaments containing them
AU6858791A (en) Uracil derivatives and pesticides containing the same as active ingredient
IL132107A0 (en) Substituted phenyl derivatives their preparation and use
AU1398892A (en) Pyrazolopyridine compound and processes for preparation thereof
AU8693491A (en) Synergism of hiv reverse transcriptase inhibitors
EP0522173A4 (en) 4-desoxy-4-epipodophyllotoxin derivative or pharmaceutically acceptable salt thereof
PH30732A (en) Dideoxydide-hydrocarbocyclic nucleosides.
EP0412940A3 (en) Hydantoin or imidazolidinetrione derivatives for the prevention or treatment of renal failure
AU5491194A (en) Cytotoxic and antiviral compound
US5378844B1 (en) 8-(1-aminocycloalkyl)-1,3-dialkylxanthine derivatives preparation process and antidepressant nootropic and psychostimulant composition thereof
EP0509098A4 (en) Ataractic
IE780530L (en) Anti-histamine salts and compositions